News ← Back to News & Events

February 4, 2016

QCL Update: Formulations Laboratory



     QCL has expanded to include an R&D Formulations Laboratory with currently available capabilities listed below for non-GMP solid oral-dosage form development, optimization and physical testing. 

      Formulation (dry-blend) development (currently up to safety Level 3 toxicity/potency

      Physical testing for solid oral dosage forms (blends & tablets)

Oral Immediate-Released tablets and capsules

Oral Controlled & Sustained Release tablets using hydrogel matrix release (no coating)

QBD (Quality–By-Design) optimization of components in existing formulations

Manual packaging (small scale) for stability studies and packaging component selection

·     Extensive experience and success in Technical Transfer, Scale Up, Optimization & Commercialization

·     Flexibility to meet client needs as they change